H5N1 Researcher to Defy Dutch Gov’t?

A virologist at the center of avian flu research controversy says he’ll publish without government permits.

Written byMegan Scudellari
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Two avian influenza A (H5N1) virionsWIKIMEDIA COMMONS, CYNTHIA GOLDSMITH/JACKIE KATZ

Ron Fouchier of Erasmus Medical Center in the Netherlands, who last September announced the creation of a mutant version of the H5N1 avian flu virus transmissible between ferrets, says that he is prepared to defy the Dutch government’s export controls that have prevented him from submitting his work for publication, according to Nature.

Earlier this month, a US biosecurity panel recommended the full publication of the his group’s paper, as well as similar research out of the University of Wisconsin, Madison—contrary to the board’s original findings last December that some of the results should be redacted. But even with the US government’s okay, Fouchier has recently complained that the Dutch government’s export laws are standing in the way. Now Fouchier says that he is prepared ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies